Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers in the US
Clinical trial NCT03537508 · COMPLETED
Trial details
- NCT number
- NCT03537508
- Sponsor
- Sanofi Pasteur, a Sanofi Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-25
- Primary completion
- 2023-09-22
- Enrollment
- 2627
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.